Tag Archives: LEDIPASVIR GS 5885

GILEAD SCIENCES SET TO GO-BUT WHERE?

With all the latest trial completed, the Sofosbuvir/Daclatasivir/Ribavirin combo is clocking 100% of the last 40 patients.  The Philadelphia GS7977 trials yielded a resounding 100%  SVR of the 40 souls on it. The Seattle, Houston and Denver trials were equally … Continue reading

Posted in HCV Health, Medical News | Tagged , , , , , , , , , , , , , , | 3 Comments